ATOSSA THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ATOSSA THERAPEUTICS, INC. (ATOS) reported Adjustments to Additional Paid in Capital, Warrant Issued of $4.12 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-06.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2015-08-06
- ATOSSA THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2012 was $762.35K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2015-06-30 | $4.12M 10-Q · filed 2015-08-06 | |
| 2012-12-31 | $762.35K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |